VIROPRO - Home

Latest News

May 2, 2016--Letter of Intent to Acquire NovaRx Expires; Viropro Appoints New Slate of Officers

December 8, 2015 --Dr. Ivor Royston, Oncologist, Entrepreneur, Investor and a Founder of San Diego Biotech, Joins Viropro Board

October 22, 2015 -- Viropro Announces Signing of Letter of Intent to Acquire NovaRx

October 9, 2015 -- Viropro Announces Appointment of Ciro E. Adams, CPA, LLC, as New Audit Firm, Secures Additional $200,000 in Convertible Debt

September 11, 2015 -- Viropro Files Complaint Against PricewaterhouseCoopers Alleging Fraud and Breach of Fiduciary Duty

February 2, 2015 -- Viropro Announces Results of Strategic Review and Plan for Restructuring

December 24, 2014 -- Viropro Opposes Sale of Alpha Assets by Receiver and Manager

October 3, 2014 -- Board Chair, Bruce Cohen, shares an open letter to Viropro Shareholders.

An Open Letter to Shareholders

September 19, 2014 -- Alpha Biologics Assets Seized by Bank Pembangunan Malaysia

August 25, 2014 -- Viropro Initiates Interim Debt Financing of Up to $500,000. Initial Closing with Spring Hill Bioventures Demonstrates Support of Largest Shareholder

June 2, 2014 – Court Recognizes Majority of Viropro Shareholders' Election of New Board of Directors

Print Sitemap
© VIROPRO

Web View Mobile View

Logout Edit page